Clinical and Pathophysiological Aspects of Curling Ulcer: A Comprehensive Exploration of its Manifestations and Therapeutic Approaches
Main Article Content
Abstract
Curling's ulcer, also known as stress ulcer, represents a medical entity of considerable significance, characterized by the formation of ulcerative lesions in the gastric or duodenal mucosa in critically ill and traumatized patients. This condition, although infrequent, imposes a significant burden in terms of morbidity and mortality, due to its unpredictable clinical manifestations and its rapid and potentially unfavorable evolution.
This article delves into the intricate pathophysiologic mechanisms underlying Curling's ulcer, highlighting the fundamental relationship with physiologic stress and hemodynamic alterations present in conditions such as extensive burns and severe trauma. The cascade of events culminating in mucosal barrier disruption, including tissue ischemia, exaggerated release of free radicals and proinflammatory cytokines, as well as imbalance in the production of gastroprotective prostaglandins, is comprehensively examined.
The clinical manifestations and diagnostic challenges associated with Curling's ulcer are explored in detail, emphasizing the need for a high index of suspicion in critically ill patients to avoid delays in detection and treatment. Modern imaging techniques and endoscopic methods that facilitate accurate assessment of ulcerative lesions and their extent are described.
In terms of therapeutic strategies, the medical and surgical approaches available to address Curling's ulcer are discussed in depth. The importance of hemodynamic support therapy and stress reduction in preventing ulcer formation is highlighted, as well as the benefits and risks of pharmacologic interventions aimed at mitigating inflammation and promoting mucosal healing are discussed. In addition, criteria for surgical intervention are discussed and guidelines for optimal procedure selection in specific clinical situations are provided.
In summary, this article provides a comprehensive overview of Curling's ulcer, from its pathophysiological basis to its clinical implications and treatment options. A detailed understanding of this essential entity in the context of critical and critical care medicine is vital to improve early identification, effective management, and ultimately outcomes in affected patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Ballesteros MA, Hogan DL, Koss MA, Isenberg Jl. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. Ann lntern Med 1990; 112: 334-339.
II. Cheung LY. Pathophysiology of stress-induced gastric mucosal erosions: an update. Surg Gastroenterol 1982; 1: 235-242.
III. Feldman M, Burton ME. Histamine 2 -receptor antagonists. Standard therapy for acid-peptic diseases (second of two parts). N Engl J Med 1990; 323: 1749-1755.
IV. Khan F, Parekh A, Patel S, Chitkara R, Rehman M, Goyal R. Results of gastric neutralization with hourly antacids and cimetidine in 320 intubated patients with respiratory failure. Chest 1981; 79: 409-412.
V. Lanza FL, Sibley CM. Role of antacids in the management of disorders of the upper gastrointestinal tract. Review of clinical experience 1975- 1985. Am J Gastroenterol 1987; 82: 1223-1241.
VI. Menguy R. The prophylaxis of stress ulceration. N Engl J Med 1980; 302: 461-462.
VII. Moody FG, Larsen KR. Acute erosions and stress ulcer. In: Bockus'gastroenterology (4th ed.). Philadelphia: Saunders, 1985; 1,004-1,012.
VIII. Morris DL, MarKham SJ, Beechey A, Hicks F, Summer, K, Lewis P et al. Ranitidine-bolus or infusion prophylaxis for stress ulcer. Crit Care Med 1988; 16: 229-232.
IX. Niederman MS, Craven DE, Fein AM, Schultz DE. Pneumonia in the critically ill hospitalized patient. Chest 1990; 97: 170-181.
X. Peura DA, Freston JW. Evolving perspectives on parenteral H2 -receptor antagonist therapy. Am J Med 1987; 83 (Suppl 6A): 1-2.
XI. Ruiz Santana S, Ruiz Santana AJ, Manzano Alonso JL. Stress ulcers. Med Clin (Barc) 1992; 99: 549-555.
XII. Schuster DP, Rowley H, Feinstein S, McGue MK, Zuckerman GR. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76: 623-630.
XIII. Skillman JJ, Bushnell LS, Goldman H, Silen W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg 1969; 117: 523-530.
XIV. Smith SM, Kvietys PR. Gastric ulcers: role of oxygen radicals. Crit Care Med 1988; 16: 892-898.
XV. Tryba M. Prevention of stress bleeding with ranitidine or pirenzepine and the risk of pneumonia. J Clin Anesth 1988; 1: 12-20.
XVI. Wilcox CM, Spenney JG. Stress ulcer prophylaxis in medical patients: who, what, and how much? Am J Gastroenterol 1988; 83: 1199-1211.
XVII. Yabana T, Yachi A. Stress-induced vascular damage and ulcer. Dig Dis Sci 1988; 33: 751-761.